Project Grant R01HL175656
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.4 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with completion targeted for March 31, 2030. The project, titled "Mapping the Molecular and Cellular Pheno-Conversion of Normal Human Coronary Artery to Atherosclerotic Plaque," delivers a clinical and pathological research...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.51M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 15, 2025, with completion anticipated by May 31, 2030. The award funds a randomized clinical trial and biomarker research initiative investigating the dysfunctional renin-angiotensin-aldosterone system (RAAS) in septic shock. The study compares the...
- Federal Project Grant Award Summary Wake Forest University received a $363,750 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026, through March 31, 2031. This award funds laboratory-based research investigating the biological mechanisms underlying severe malarial anemia (SMA), a potentially lethal complication affecting patients infected with Plasmodium falciparum parasites. The...
- Federal Grant Award Summary Brigham and Women's Hospital received an award of $855,585 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with an award date of August 20, 2025, and a completion date of July 31, 2028. This Project Grant funds the development and adaptation of an antihypertensive self-titration intervention for routine implementation in U.S. primary care settings. The project addresses the clinical challenge...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Denver a Project Grant totaling $169,638 (awarded July 15, 2026) under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the relationship between neighborhood food access and cardiovascular disease (CVD) risk in early childhood. The research leverages two prospective cohorts—the geographically diverse Environmental Influences on Child Health Outcomes (ECHO) cohort...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $1,393,890 to the University of North Carolina at Chapel Hill under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2025, for a five-year project examining crossover effects of adolescent stress on parent cardiovascular health. This research initiative will identify associations between daily stressors experienced by adolescents and two cardiovascular disease (CVD) risk factors in...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1,532,545 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for February 29, 2028. The project examines the effects of income-based health insurance benefit designs on cardiovascular disease (CVD) outcomes and health disparities among working-age adults. Specifically, the...
- Federal Project Grant Award Summary Emory University received a $156,080 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded March 13, 2026, with completion targeted for September 11, 2027. The grant supports research investigating HEG1 (Heart of Glass 1) as a regulator of hypertension and atherosclerosis, addressing a critical gap in understanding the molecular and cellular mechanisms underlying these...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Washington a Project Grant of $186,408 (awarded September 1, 2025; completion date August 31, 2030) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop predictive models for identifying patients at high risk for persistent hypoxemic respiratory failure (HRF). The research addresses a critical clinical need by leveraging machine learning and data science to analyze...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Children's Hospital of Philadelphia Research Institute a $889,804 Project Grant on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds basic and translational research investigating MED12 (Mediator Complex Subunit 12) as a novel regulator of vasculogenesis, with completion targeted for March 31, 2031. The research leverages a MED12-deficient zebrafish...
Wake Forest University Health Sciences received a $881,454 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 15, 2026, with completion expected March 31, 2031. The grant supports the SUPERHERO (Study of the Epidemiology of Pediatric Hypertension) Registry, which will establish standardized methods to harmonize and analyze longitudinal data from 45,000 youth across 12 clinical sites to examine the relationships between food insecurity, inadequate clinical care, and hypertension progression in youth populations. The deliverables include: (1) development of validated data harmonization methodologies to integrate heterogeneous electronic health record data across multiple healthcare systems; (2) longitudinal epidemiologic analysis characterizing barriers to guideline-based hypertension care and healthy food access in youth; and (3) qualitative research synthesizing patient, caregiver, and healthcare provider perspectives to identify evidence-based strategies for overcoming these barriers. The research infrastructure and findings will support the long-term goal of designing multistage interventions targeting healthcare delivery barriers to improve clinical outcomes and cardiovascular health across the life course for youth with hypertension disorders.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $881.5k | 7/8/26 |